Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "BridgeBio"
showing the first 40- Eidos Therapeutics, Inc.425 · 2020-10-05Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)SC 13D · 2020-10-15Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)10-K · 2020-03-03Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2020-12-28Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2020-10-05Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)425 · 2020-10-06Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-01-29Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2020-12-29Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)S-1/A · 2019-06-24Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)S-4/A · 2020-12-11Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2021-01-13Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2021-01-13Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2020-10-06Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)S-4 · 2020-11-06Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2021-01-04Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2022-05-13Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2020-10-07Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.8-K · 2020-10-05Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2021-01-12Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2020-03-10Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2024-08-21Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.425 · 2021-01-07Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)424B3 · 2020-12-15Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-01-12Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.8-K · 2020-10-07Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-01-20Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)DEFM14A · 2020-12-15Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2026-01-21Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-01-20Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2025-02-28Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-01-26Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.SC 13D/A · 2019-10-15Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2020-01-07Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2024-11-25Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.8-K · 2020-10-05Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2020-11-05Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)425 · 2020-10-05Read the filing on SEC.gov →
- Eidos Therapeutics, Inc.DEFM14A · 2020-12-15Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2022-05-10Read the filing on SEC.gov →
- BridgeBio Pharma, Inc. (BBIO)8-K · 2021-02-26Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.